To, Kenneth K.W.

HIF-1α Induces Genetic Instability by Transcriptionally Downregulating MutSα Expression

Koshiji, M., To, K. K.-W., Hammer, S., Kumamoto, K., Harris, A. L., Modrich, P., & Huang, L. E. (2005) · Molecular Cell

Cancer, Hypoxia, and MetabolismDNA Repair Mechanisms

Cited by 346

Apatinib (YN968D1) Reverses Multidrug Resistance by Inhibiting the Efflux Function of Multiple ATP-Binding Cassette Transporters

Mi, Y.-J., Liang, Y.-J., Huang, H.-B., Zhao, H.-Y., Wu, C.-P., Wang, F., Tao, L.-Y., Zhang, C.-Z., Dai, C.-L., Tiwari, A. K., et al. (2010) · Cancer Research

Drug Transport and Resistance MechanismsAntibiotic Resistance in Bacteria

Cited by 337

Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2

To, K. K. W., Robey, R. W., Knutsen, T., Zhan, Z., Ried, T., & Bates, S. E. (2009) · Molecular Cancer Therapeutics

Drug Transport and Resistance MechanismsMicroRNA in disease regulation

Cited by 112

An overview of rational design of mRNA-based therapeutics and vaccines

To, K. K. W., & Cho, W. C. S. (2021) · Expert Opinion on Drug Discovery

RNA Interference and Gene DeliveryRNA and protein synthesis mechanisms

Cited by 110

Anthracenedione derivatives as anticancer agents isolated from secondary metabolites of the mangrove endophytic fungi

Zhang, J.-Y., Tao, L.-Y., Liang, Y.-J., Chen, L.-M., Mi, Y.-J., Zheng, L.-S., Wang, F., She, Z.-G., Lin, Y.-C., To, K. K. W., et al. (2010) · Marine Drugs

Microbial Natural Products and BiosynthesisMarine Sponges and Natural Products

Cited by 103

Reversal of P-glycoprotein (P-gp) mediated multidrug resistance in colon cancer cells by cryptotanshinone and dihydrotanshinone of Salvia miltiorrhiza.

Hu, T., To, K. K. W., Wang, L., Zhang, L., Lu, L., Shen, J., Chan, R. L. Y., Li, M., Yeung, J. H. K., & Cho, C. H. (2014) · Phytomedicine

Drug Transport and Resistance MechanismsTraditional Chinese Medicine Analysis

Cited by 99

Exploiting a novel miR-519c–HuR–ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer

To, K. K. W., Leung, W. W., & Ng, S. S. M. (2015) · Experimental Cell Research

Drug Transport and Resistance MechanismsMicroRNA in disease regulation

Cited by 99

Drug repurposing to overcome resistance to various therapies for colorectal cancer

Fong, W., & To, K. K. W. (2019) · Cellular and Molecular Life Sciences

Colorectal Cancer Treatments and StudiesMetabolism, Diabetes, and Cancer

Cited by 81

Micellar delivery of dasatinib for the inhibition of pathologic cellular processes of the retinal pigment epithelium

Li, Q., Lai, K. L., Chan, P. S., Leung, S. C., Li, H. Y., Fang, Y., To, K. K. W., Choi, C. H. J., Gao, Q. Y., & Lee, T. W. Y. (2016) · Colloids and Surfaces B Biointerfaces

Nanoparticle-Based Drug DeliveryAdvanced Drug Delivery Systems

Cited by 67

Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxia

To, K. K. W., Poon, D. C., Wei, Y., Wang, F., Lin, G., & Fu, L.-W. (2015) · Biochemical Pharmacology

Drug Transport and Resistance MechanismsCancer Cells and Metastasis

Cited by 49